Formulations comprising arachidonic acid (AA) and docosahexanoic acid (DHA) in nutritionally complete beverages

摘要

The use of arachidonic acid (AA) and docosahexanoic (DHA) acid in the manufacture of a medicament for the treatment of short bowel syndrome is described. Short bowel syndrome is the term used to describe the state of nutrient malabsorption following extensive surgical resection of the small intestine. The treatment is given to human patients in need thereof.